# Helicobacter Pylori First-line Treatment Containing Tetracycline in Patients Allergic to Penicillin

> **NCT05129176** · PHASE4 · UNKNOWN · sponsor: **Shandong University** · enrollment: 106 (estimated)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Levofloxacin
- **DRUG:** Metronidazole

## Key facts

- **NCT ID:** NCT05129176
- **Lead sponsor:** Shandong University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-23
- **Primary completion:** 2022-07
- **Final completion:** 2022-11
- **Target enrollment:** 106 (ESTIMATED)
- **Last updated:** 2021-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05129176

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05129176, "Helicobacter Pylori First-line Treatment Containing Tetracycline in Patients Allergic to Penicillin". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05129176. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*